Celldex Therapeutics, Inc. (GETTEX:TCE2) Cap table
Cap table
Built by 6ix from Celldex Therapeutics, Inc.’s releases · as of Oct 28, 2026
- Common shares
- 78,545,051
- Fully diluted
- 78,545,051
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 78,545,051 | Oct 28, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 28, 2026 | 78,545,051 |